Clinical Trials Directory

Trials / Completed

CompletedNCT06933784

Evaluation of Wnt5a and LRP5 Levels in Serum and Saliva Samples and the Relationship Between Clinical Periodontal Parameters

Expression of Wnt5a and WNT Coreceptor (LRP5) Levels in Stage III Periodontitis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Ankara University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Objectives: Wnt5a is a secreted Wnt ligand that plays an important role in cellular homeostasis. Wnt interaction with coreceptor low-density lipoprotein receptor-related protein 5 (LRP5) induces the proliferation of osteoblasts and prolongs their functional life. The aim of this study is evaluating the levels of Wnt5a and LRP5 in serum and saliva samples and relationship between clinical periodontal parameters. Method: Saliva and serum samples were collected from 20 systemically healthy patients with stage III periodontitis and 20 periodontally healthy controls. Wnt5a and LRP5 levels were measured using enzyme-linked immunosorbent assay (ELISA). Clinical periodontal parameters including plaque index (PI), probing pocket depth (PPD), bleeding on probing (BOP), and clinical attachment level (CAL) were recorded.

Conditions

Timeline

Start date
2024-04-01
Primary completion
2024-10-01
Completion
2025-03-01
First posted
2025-04-18
Last updated
2025-04-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06933784. Inclusion in this directory is not an endorsement.